CreditReports.dk
HomeScreen companies

Orocidin A/S Financials, key figures and credit report

CVR number: 44348845 Established 2023 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Vandtårnsvej 62 A, 2860 Søborg info@orocidin.com tel: 42901733 www.orocidin.com
Gross profit - 705.7 kDKK FY 2025 +47.8% vs 2024
EBIT - 718.5 kDKK FY 2025 +47.2% vs 2024
Net debt 3 242.7 kDKK FY 2025 +95.1% vs 2024
Quick ratio 0.1 FY 2025 +0 vs 2024

Income statement (kDKK)

2024
2025
Fiscal period length1212
Net sales
Gross profit-1 351.23- 705.72
Wages and salaries- 134.60
Social security expenses- 134.60
Total depreciation-10.83-12.78
EBIT-1 362.07- 718.50
Other financial income180.96
Other financial expenses-29.12-1.22
Pre-tax profit-1 391.18- 538.76
Net earnings-1 391.18- 538.76

Assets (kDKK)

2024
2025
Development expenditure8 955.7414 463.00
Intangible rights21.6743.89
Intangible assets total8 977.4114 506.89
Tangible assets total
Investments total16.50
Long term receivables total
Inventories total
Current amounts owed by group member comp.32.7431.43
Prepayments and accrued income18.231.49
Current other receivables291.33447.76
Short term receivables total342.30480.69
Cash and bank deposits23.86
Cash and cash equivalents23.86
Balance sheet total (assets)9 319.7115 027.94

Equity and liabilities (kDKK)

2024
2025
Share capital555.26565.03
Share premium account3 777.0011 328.88
Other reserves6 985.4811 281.14
Retained earnings-6 985.48-12 672.32
Profit of the financial year-1 391.18- 538.76
Shareholders equity total2 941.089 963.97
Non-current liabilities total
Current trade creditors4 716.871 670.85
Current owed to group member1 661.763 266.60
Other non-interest bearing current liabilities126.51
Current liabilities total6 378.635 063.96
Balance sheet total (liabilities)9 319.7115 027.94
Page generated